nodes	percent_of_prediction	percent_of_DWPC	metapath
Isocarboxazid—Lacosamide—Nateglinide—type 2 diabetes mellitus	0.267	0.355	CrCrCtD
Isocarboxazid—Phenacemide—Nateglinide—type 2 diabetes mellitus	0.181	0.241	CrCrCtD
Isocarboxazid—Methamphetamine—Nateglinide—type 2 diabetes mellitus	0.171	0.227	CrCrCtD
Isocarboxazid—L-Phenylalanine—Nateglinide—type 2 diabetes mellitus	0.134	0.178	CrCrCtD
Isocarboxazid—MAOB—nerve—type 2 diabetes mellitus	0.00306	0.154	CbGeAlD
Isocarboxazid—MAOA—nerve—type 2 diabetes mellitus	0.00261	0.131	CbGeAlD
Isocarboxazid—MAOB—Alpha-synuclein signaling—GRK5—type 2 diabetes mellitus	0.00254	0.0419	CbGpPWpGaD
Isocarboxazid—MAOA—Biogenic Amine Synthesis—GAD2—type 2 diabetes mellitus	0.00228	0.0376	CbGpPWpGaD
Isocarboxazid—MAOB—Dopamine metabolism—SOD1—type 2 diabetes mellitus	0.00203	0.0334	CbGpPWpGaD
Isocarboxazid—MAOA—Melatonin metabolism and effects—ECE1—type 2 diabetes mellitus	0.00189	0.0311	CbGpPWpGaD
Isocarboxazid—MAOA—Serotonin Transporter Activity—NOS1—type 2 diabetes mellitus	0.00168	0.0276	CbGpPWpGaD
Isocarboxazid—MAOB—Dopamine metabolism—PPP2CA—type 2 diabetes mellitus	0.00167	0.0276	CbGpPWpGaD
Isocarboxazid—Photosensitivity reaction—Chlorpropamide—type 2 diabetes mellitus	0.00155	0.00932	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Tolazamide—type 2 diabetes mellitus	0.00155	0.00932	CcSEcCtD
Isocarboxazid—Coma—Glimepiride—type 2 diabetes mellitus	0.00153	0.00921	CcSEcCtD
Isocarboxazid—Sleep disturbance—Ramipril—type 2 diabetes mellitus	0.00141	0.00848	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Nateglinide—type 2 diabetes mellitus	0.00137	0.00827	CcSEcCtD
Isocarboxazid—Inappropriate antidiuretic hormone secretion—Ramipril—type 2 diabetes mellitus	0.00136	0.00818	CcSEcCtD
Isocarboxazid—Sweating—Nateglinide—type 2 diabetes mellitus	0.00134	0.00809	CcSEcCtD
Isocarboxazid—MAOA—Dopamine metabolism—SOD1—type 2 diabetes mellitus	0.00127	0.021	CbGpPWpGaD
Isocarboxazid—MAOA—Norepinephrine Neurotransmitter Release Cycle—SNAP25—type 2 diabetes mellitus	0.00127	0.0209	CbGpPWpGaD
Isocarboxazid—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.00126	0.0635	CbGeAlD
Isocarboxazid—MAOB—nephron tubule—type 2 diabetes mellitus	0.00119	0.0599	CbGeAlD
Isocarboxazid—Memory impairment—Losartan—type 2 diabetes mellitus	0.00117	0.00707	CcSEcCtD
Isocarboxazid—Coma—Gliclazide—type 2 diabetes mellitus	0.00113	0.00682	CcSEcCtD
Isocarboxazid—Lethargy—Bromocriptine—type 2 diabetes mellitus	0.00112	0.00673	CcSEcCtD
Isocarboxazid—Orthostatic hypotension—Sitagliptin—type 2 diabetes mellitus	0.0011	0.00666	CcSEcCtD
Isocarboxazid—MAOA—retina—type 2 diabetes mellitus	0.00108	0.0543	CbGeAlD
Isocarboxazid—MAOB—cardiovascular system—type 2 diabetes mellitus	0.00107	0.0538	CbGeAlD
Isocarboxazid—Dysuria—Glipizide—type 2 diabetes mellitus	0.00105	0.00634	CcSEcCtD
Isocarboxazid—MAOA—Dopamine metabolism—PPP2CA—type 2 diabetes mellitus	0.00105	0.0173	CbGpPWpGaD
Isocarboxazid—MAOB—kidney—type 2 diabetes mellitus	0.00105	0.0526	CbGeAlD
Isocarboxazid—Urinary retention—Bromocriptine—type 2 diabetes mellitus	0.00104	0.00628	CcSEcCtD
Isocarboxazid—Sleep disorder—Gliclazide—type 2 diabetes mellitus	0.00104	0.00626	CcSEcCtD
Isocarboxazid—Ataxia—Bromocriptine—type 2 diabetes mellitus	0.00103	0.00621	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Glipizide—type 2 diabetes mellitus	0.00103	0.00618	CcSEcCtD
Isocarboxazid—Tremor—Nateglinide—type 2 diabetes mellitus	0.00102	0.00618	CcSEcCtD
Isocarboxazid—Photosensitivity—Gliclazide—type 2 diabetes mellitus	0.00102	0.00617	CcSEcCtD
Isocarboxazid—MAOB—cortex of kidney—type 2 diabetes mellitus	0.00102	0.0513	CbGeAlD
Isocarboxazid—MAOA—nephron tubule—type 2 diabetes mellitus	0.00102	0.0511	CbGeAlD
Isocarboxazid—Constipation—Miglitol—type 2 diabetes mellitus	0.00101	0.00607	CcSEcCtD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.001	0.0166	CbGpPWpGaD
Isocarboxazid—Drowsiness—Glipizide—type 2 diabetes mellitus	0.001	0.00604	CcSEcCtD
Isocarboxazid—Orthostatic hypotension—Bromocriptine—type 2 diabetes mellitus	0.001	0.00603	CcSEcCtD
Isocarboxazid—MAOA—Neurotransmitter Release Cycle—GAD2—type 2 diabetes mellitus	0.000999	0.0165	CbGpPWpGaD
Isocarboxazid—Erectile dysfunction—Pioglitazone—type 2 diabetes mellitus	0.000992	0.00598	CcSEcCtD
Isocarboxazid—Pollakiuria—Glimepiride—type 2 diabetes mellitus	0.000969	0.00584	CcSEcCtD
Isocarboxazid—Palpitations—Nateglinide—type 2 diabetes mellitus	0.000966	0.00583	CcSEcCtD
Isocarboxazid—Erectile dysfunction—Sitagliptin—type 2 diabetes mellitus	0.000963	0.00581	CcSEcCtD
Isocarboxazid—Sweating—Glipizide—type 2 diabetes mellitus	0.000961	0.00579	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Glimepiride—type 2 diabetes mellitus	0.000957	0.00577	CcSEcCtD
Isocarboxazid—MAOB—adipose tissue—type 2 diabetes mellitus	0.000945	0.0474	CbGeAlD
Isocarboxazid—Sleep disorder—Orlistat—type 2 diabetes mellitus	0.000942	0.00568	CcSEcCtD
Isocarboxazid—Photosensitivity—Valsartan—type 2 diabetes mellitus	0.00094	0.00567	CcSEcCtD
Isocarboxazid—Drowsiness—Glimepiride—type 2 diabetes mellitus	0.000935	0.00564	CcSEcCtD
Isocarboxazid—Sweating—Pioglitazone—type 2 diabetes mellitus	0.00092	0.00555	CcSEcCtD
Isocarboxazid—MAOA—cardiovascular system—type 2 diabetes mellitus	0.000914	0.0459	CbGeAlD
Isocarboxazid—Neuropathy peripheral—Sitagliptin—type 2 diabetes mellitus	0.000914	0.00551	CcSEcCtD
Isocarboxazid—Sweating—Glimepiride—type 2 diabetes mellitus	0.000896	0.0054	CcSEcCtD
Isocarboxazid—MAOA—kidney—type 2 diabetes mellitus	0.000895	0.0449	CbGeAlD
Isocarboxazid—MAOA—pancreas—type 2 diabetes mellitus	0.000889	0.0446	CbGeAlD
Isocarboxazid—Pollakiuria—Bromocriptine—type 2 diabetes mellitus	0.000874	0.00527	CcSEcCtD
Isocarboxazid—MAOB—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.000872	0.0144	CbGpPWpGaD
Isocarboxazid—MAOA—cortex of kidney—type 2 diabetes mellitus	0.000871	0.0437	CbGeAlD
Isocarboxazid—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.000863	0.0052	CcSEcCtD
Isocarboxazid—MAOB—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.000863	0.0142	CbGpPWpGaD
Isocarboxazid—Drowsiness—Bromocriptine—type 2 diabetes mellitus	0.000844	0.00509	CcSEcCtD
Isocarboxazid—MAOB—Tryptophan metabolism—CYP3A4—type 2 diabetes mellitus	0.000841	0.0139	CbGpPWpGaD
Isocarboxazid—Palpitations—Repaglinide—type 2 diabetes mellitus	0.000836	0.00504	CcSEcCtD
Isocarboxazid—Sleep disorder—Irbesartan—type 2 diabetes mellitus	0.00082	0.00494	CcSEcCtD
Isocarboxazid—MAOA—Oxidative Stress—CYBA—type 2 diabetes mellitus	0.000816	0.0135	CbGpPWpGaD
Isocarboxazid—Constipation—Linagliptin—type 2 diabetes mellitus	0.000815	0.00492	CcSEcCtD
Isocarboxazid—Photosensitivity—Irbesartan—type 2 diabetes mellitus	0.000808	0.00487	CcSEcCtD
Isocarboxazid—Chills—Glipizide—type 2 diabetes mellitus	0.000807	0.00487	CcSEcCtD
Isocarboxazid—MAOA—adipose tissue—type 2 diabetes mellitus	0.000806	0.0405	CbGeAlD
Isocarboxazid—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.000806	0.00486	CcSEcCtD
Isocarboxazid—Constipation—Acarbose—type 2 diabetes mellitus	0.000791	0.00477	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Glyburide—type 2 diabetes mellitus	0.000789	0.00476	CcSEcCtD
Isocarboxazid—MAOA—Melatonin metabolism and effects—CYP1A2—type 2 diabetes mellitus	0.000783	0.0129	CbGpPWpGaD
Isocarboxazid—Sleep disorder—Losartan—type 2 diabetes mellitus	0.000771	0.00465	CcSEcCtD
Isocarboxazid—Lethargy—Metformin—type 2 diabetes mellitus	0.000767	0.00463	CcSEcCtD
Isocarboxazid—Photosensitivity—Losartan—type 2 diabetes mellitus	0.00076	0.00458	CcSEcCtD
Isocarboxazid—Orthostatic hypotension—Valsartan—type 2 diabetes mellitus	0.000754	0.00455	CcSEcCtD
Isocarboxazid—Hallucination—Bromocriptine—type 2 diabetes mellitus	0.000753	0.00454	CcSEcCtD
Isocarboxazid—MAOB—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.000749	0.0124	CbGpPWpGaD
Isocarboxazid—Tremor—Glipizide—type 2 diabetes mellitus	0.000734	0.00442	CcSEcCtD
Isocarboxazid—Erectile dysfunction—Gliclazide—type 2 diabetes mellitus	0.000715	0.00431	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Gliclazide—type 2 diabetes mellitus	0.000709	0.00427	CcSEcCtD
Isocarboxazid—Syncope—Glipizide—type 2 diabetes mellitus	0.000702	0.00423	CcSEcCtD
Isocarboxazid—MAOB—Tryptophan metabolism—CAT—type 2 diabetes mellitus	0.0007	0.0115	CbGpPWpGaD
Isocarboxazid—Nausea—Miglitol—type 2 diabetes mellitus	0.000699	0.00422	CcSEcCtD
Isocarboxazid—Paraesthesia—Repaglinide—type 2 diabetes mellitus	0.000694	0.00418	CcSEcCtD
Isocarboxazid—MAOB—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.000693	0.0114	CbGpPWpGaD
Isocarboxazid—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.000692	0.00417	CcSEcCtD
Isocarboxazid—Loss of consciousness—Glipizide—type 2 diabetes mellitus	0.000688	0.00415	CcSEcCtD
Isocarboxazid—Tremor—Glimepiride—type 2 diabetes mellitus	0.000685	0.00413	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Gliclazide—type 2 diabetes mellitus	0.000679	0.00409	CcSEcCtD
Isocarboxazid—Agitation—Glimepiride—type 2 diabetes mellitus	0.000672	0.00405	CcSEcCtD
Isocarboxazid—Sweating—Gliclazide—type 2 diabetes mellitus	0.000664	0.004	CcSEcCtD
Isocarboxazid—Headache—Tolbutamide—type 2 diabetes mellitus	0.000663	0.004	CcSEcCtD
Isocarboxazid—MAOB—liver—type 2 diabetes mellitus	0.000663	0.0333	CbGeAlD
Isocarboxazid—Sleep disorder—Ramipril—type 2 diabetes mellitus	0.000661	0.00399	CcSEcCtD
Isocarboxazid—Constipation—Repaglinide—type 2 diabetes mellitus	0.000661	0.00398	CcSEcCtD
Isocarboxazid—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000659	0.00397	CcSEcCtD
Isocarboxazid—Erectile dysfunction—Valsartan—type 2 diabetes mellitus	0.000657	0.00396	CcSEcCtD
Isocarboxazid—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.000652	0.00393	CcSEcCtD
Isocarboxazid—Photosensitivity—Ramipril—type 2 diabetes mellitus	0.000652	0.00393	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Valsartan—type 2 diabetes mellitus	0.000651	0.00393	CcSEcCtD
Isocarboxazid—MAOA—Oxidative Stress—SOD1—type 2 diabetes mellitus	0.000651	0.0107	CbGpPWpGaD
Isocarboxazid—Orthostatic hypotension—Irbesartan—type 2 diabetes mellitus	0.000648	0.00391	CcSEcCtD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.000647	0.0107	CbGpPWpGaD
Isocarboxazid—Palpitations—Glimepiride—type 2 diabetes mellitus	0.000646	0.00389	CcSEcCtD
Isocarboxazid—MAOA—Neurotransmitter Release Cycle—SNAP25—type 2 diabetes mellitus	0.000644	0.0106	CbGpPWpGaD
Isocarboxazid—Loss of consciousness—Glimepiride—type 2 diabetes mellitus	0.000642	0.00387	CcSEcCtD
Isocarboxazid—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000637	0.00384	CcSEcCtD
Isocarboxazid—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000637	0.00384	CcSEcCtD
Isocarboxazid—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000633	0.00382	CcSEcCtD
Isocarboxazid—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000629	0.00379	CcSEcCtD
Isocarboxazid—Shock—Glipizide—type 2 diabetes mellitus	0.000629	0.00379	CcSEcCtD
Isocarboxazid—Ataxia—Losartan—type 2 diabetes mellitus	0.000628	0.00379	CcSEcCtD
Isocarboxazid—MAOA—Oxidative Stress—HMOX1—type 2 diabetes mellitus	0.000627	0.0103	CbGpPWpGaD
Isocarboxazid—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.000624	0.00376	CcSEcCtD
Isocarboxazid—MAOA—Oxidative Stress—CAT—type 2 diabetes mellitus	0.000618	0.0102	CbGpPWpGaD
Isocarboxazid—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000618	0.00372	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Orlistat—type 2 diabetes mellitus	0.000616	0.00372	CcSEcCtD
Isocarboxazid—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000611	0.00368	CcSEcCtD
Isocarboxazid—Orthostatic hypotension—Losartan—type 2 diabetes mellitus	0.00061	0.00368	CcSEcCtD
Isocarboxazid—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.000608	0.00367	CcSEcCtD
Isocarboxazid—MAOA—Melatonin metabolism and effects—EDN1—type 2 diabetes mellitus	0.000607	0.01	CbGpPWpGaD
Isocarboxazid—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.000606	0.00366	CcSEcCtD
Isocarboxazid—Agitation—Bromocriptine—type 2 diabetes mellitus	0.000606	0.00365	CcSEcCtD
Isocarboxazid—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000603	0.00364	CcSEcCtD
Isocarboxazid—Headache—Tolazamide—type 2 diabetes mellitus	0.000603	0.00364	CcSEcCtD
Isocarboxazid—Headache—Linagliptin—type 2 diabetes mellitus	0.000597	0.0036	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000592	0.00357	CcSEcCtD
Isocarboxazid—Syncope—Bromocriptine—type 2 diabetes mellitus	0.000591	0.00356	CcSEcCtD
Isocarboxazid—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00059	0.00356	CcSEcCtD
Isocarboxazid—Shock—Glimepiride—type 2 diabetes mellitus	0.000587	0.00354	CcSEcCtD
Isocarboxazid—MAOA—Oxidative Stress—SOD2—type 2 diabetes mellitus	0.000586	0.00967	CbGpPWpGaD
Isocarboxazid—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.000579	0.00349	CcSEcCtD
Isocarboxazid—Drowsiness—Metformin—type 2 diabetes mellitus	0.000579	0.00349	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000577	0.00348	CcSEcCtD
Isocarboxazid—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.000574	0.00346	CcSEcCtD
Isocarboxazid—Nausea—Tolazamide—type 2 diabetes mellitus	0.000572	0.00345	CcSEcCtD
Isocarboxazid—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000572	0.00345	CcSEcCtD
Isocarboxazid—MAOB—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.000572	0.00943	CbGpPWpGaD
Isocarboxazid—Somnolence—Glipizide—type 2 diabetes mellitus	0.000568	0.00343	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Metformin—type 2 diabetes mellitus	0.000568	0.00342	CcSEcCtD
Isocarboxazid—MAOA—liver—type 2 diabetes mellitus	0.000565	0.0284	CbGeAlD
Isocarboxazid—MAOB—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.000565	0.00933	CbGpPWpGaD
Isocarboxazid—Tremor—Glyburide—type 2 diabetes mellitus	0.000565	0.0034	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.00056	0.00337	CcSEcCtD
Isocarboxazid—MAOA—Oxidative Stress—GPX1—type 2 diabetes mellitus	0.000559	0.00923	CbGpPWpGaD
Isocarboxazid—Chills—Gliclazide—type 2 diabetes mellitus	0.000558	0.00336	CcSEcCtD
Isocarboxazid—MAOB—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.000551	0.0091	CbGpPWpGaD
Isocarboxazid—Nausea—Acarbose—type 2 diabetes mellitus	0.00055	0.00331	CcSEcCtD
Isocarboxazid—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000549	0.00331	CcSEcCtD
Isocarboxazid—Constipation—Glipizide—type 2 diabetes mellitus	0.000546	0.00329	CcSEcCtD
Isocarboxazid—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000536	0.00323	CcSEcCtD
Isocarboxazid—Pollakiuria—Losartan—type 2 diabetes mellitus	0.000533	0.00321	CcSEcCtD
Isocarboxazid—Erectile dysfunction—Losartan—type 2 diabetes mellitus	0.000531	0.0032	CcSEcCtD
Isocarboxazid—Somnolence—Glimepiride—type 2 diabetes mellitus	0.00053	0.0032	CcSEcCtD
Isocarboxazid—Nausea—Nateglinide—type 2 diabetes mellitus	0.00053	0.0032	CcSEcCtD
Isocarboxazid—Shock—Bromocriptine—type 2 diabetes mellitus	0.000529	0.00319	CcSEcCtD
Isocarboxazid—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000528	0.00319	CcSEcCtD
Isocarboxazid—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000528	0.00319	CcSEcCtD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.000528	0.00871	CbGpPWpGaD
Isocarboxazid—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000527	0.00318	CcSEcCtD
Isocarboxazid—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000523	0.00315	CcSEcCtD
Isocarboxazid—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000508	0.00307	CcSEcCtD
Isocarboxazid—Tremor—Gliclazide—type 2 diabetes mellitus	0.000507	0.00306	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Losartan—type 2 diabetes mellitus	0.000504	0.00304	CcSEcCtD
Isocarboxazid—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000499	0.00301	CcSEcCtD
Isocarboxazid—Agitation—Gliclazide—type 2 diabetes mellitus	0.000497	0.003	CcSEcCtD
Isocarboxazid—MAOA—Melatonin metabolism and effects—CALM1—type 2 diabetes mellitus	0.000495	0.00817	CbGpPWpGaD
Isocarboxazid—MAOA—Melatonin metabolism and effects—APOE—type 2 diabetes mellitus	0.000494	0.00814	CbGpPWpGaD
Isocarboxazid—Sweating—Losartan—type 2 diabetes mellitus	0.000493	0.00297	CcSEcCtD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000491	0.00809	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000491	0.00809	CbGpPWpGaD
Isocarboxazid—Headache—Repaglinide—type 2 diabetes mellitus	0.000484	0.00292	CcSEcCtD
Isocarboxazid—Shock—Glyburide—type 2 diabetes mellitus	0.000484	0.00292	CcSEcCtD
Isocarboxazid—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000483	0.00291	CcSEcCtD
Isocarboxazid—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000483	0.00291	CcSEcCtD
Isocarboxazid—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000478	0.00288	CcSEcCtD
Isocarboxazid—MAOA—Neuronal System—KCNK16—type 2 diabetes mellitus	0.000478	0.00789	CbGpPWpGaD
Isocarboxazid—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000478	0.00288	CcSEcCtD
Isocarboxazid—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000476	0.00287	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000475	0.00287	CcSEcCtD
Isocarboxazid—MAOA—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.00047	0.00775	CbGpPWpGaD
Isocarboxazid—Chills—Metformin—type 2 diabetes mellitus	0.000467	0.00281	CcSEcCtD
Isocarboxazid—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00046	0.00277	CcSEcCtD
Isocarboxazid—Nausea—Repaglinide—type 2 diabetes mellitus	0.000459	0.00277	CcSEcCtD
Isocarboxazid—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000457	0.00276	CcSEcCtD
Isocarboxazid—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000456	0.00275	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000452	0.00272	CcSEcCtD
Isocarboxazid—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000451	0.00272	CcSEcCtD
Isocarboxazid—Syncope—Valsartan—type 2 diabetes mellitus	0.000446	0.00269	CcSEcCtD
Isocarboxazid—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000442	0.00266	CcSEcCtD
Isocarboxazid—Chills—Irbesartan—type 2 diabetes mellitus	0.00044	0.00266	CcSEcCtD
Isocarboxazid—Palpitations—Valsartan—type 2 diabetes mellitus	0.000439	0.00265	CcSEcCtD
Isocarboxazid—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000437	0.00264	CcSEcCtD
Isocarboxazid—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000437	0.00263	CcSEcCtD
Isocarboxazid—MAOA—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.000435	0.00717	CbGpPWpGaD
Isocarboxazid—Palpitations—Orlistat—type 2 diabetes mellitus	0.000434	0.00262	CcSEcCtD
Isocarboxazid—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000434	0.00261	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000432	0.00261	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000427	0.00257	CcSEcCtD
Isocarboxazid—Tremor—Metformin—type 2 diabetes mellitus	0.000424	0.00256	CcSEcCtD
Isocarboxazid—Sweating—Ramipril—type 2 diabetes mellitus	0.000423	0.00255	CcSEcCtD
Isocarboxazid—Dizziness—Glipizide—type 2 diabetes mellitus	0.000423	0.00255	CcSEcCtD
Isocarboxazid—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000419	0.00253	CcSEcCtD
Isocarboxazid—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000414	0.0025	CcSEcCtD
Isocarboxazid—MAOB—Alpha-synuclein signaling—SRC—type 2 diabetes mellitus	0.000413	0.00682	CbGpPWpGaD
Isocarboxazid—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000409	0.00247	CcSEcCtD
Isocarboxazid—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000408	0.00246	CcSEcCtD
Isocarboxazid—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000407	0.00245	CcSEcCtD
Isocarboxazid—Syncope—Metformin—type 2 diabetes mellitus	0.000406	0.00245	CcSEcCtD
Isocarboxazid—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000405	0.00244	CcSEcCtD
Isocarboxazid—Headache—Glipizide—type 2 diabetes mellitus	0.0004	0.00241	CcSEcCtD
Isocarboxazid—Tremor—Irbesartan—type 2 diabetes mellitus	0.0004	0.00241	CcSEcCtD
Isocarboxazid—Palpitations—Metformin—type 2 diabetes mellitus	0.0004	0.00241	CcSEcCtD
Isocarboxazid—Shock—Valsartan—type 2 diabetes mellitus	0.000399	0.00241	CcSEcCtD
Isocarboxazid—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000398	0.0024	CcSEcCtD
Isocarboxazid—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000397	0.00239	CcSEcCtD
Isocarboxazid—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000394	0.00238	CcSEcCtD
Isocarboxazid—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000393	0.00237	CcSEcCtD
Isocarboxazid—Agitation—Irbesartan—type 2 diabetes mellitus	0.000393	0.00237	CcSEcCtD
Isocarboxazid—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000393	0.00237	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000388	0.00234	CcSEcCtD
Isocarboxazid—Headache—Pioglitazone—type 2 diabetes mellitus	0.000384	0.00231	CcSEcCtD
Isocarboxazid—Syncope—Irbesartan—type 2 diabetes mellitus	0.000383	0.00231	CcSEcCtD
Isocarboxazid—MAOB—Biological oxidations—MTR—type 2 diabetes mellitus	0.00038	0.00627	CbGpPWpGaD
Isocarboxazid—Nausea—Glipizide—type 2 diabetes mellitus	0.00038	0.00229	CcSEcCtD
Isocarboxazid—Constipation—Gliclazide—type 2 diabetes mellitus	0.000378	0.00228	CcSEcCtD
Isocarboxazid—Tremor—Losartan—type 2 diabetes mellitus	0.000377	0.00227	CcSEcCtD
Isocarboxazid—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000376	0.00226	CcSEcCtD
Isocarboxazid—Headache—Glimepiride—type 2 diabetes mellitus	0.000374	0.00225	CcSEcCtD
Isocarboxazid—Headache—Sitagliptin—type 2 diabetes mellitus	0.000372	0.00225	CcSEcCtD
Isocarboxazid—Agitation—Losartan—type 2 diabetes mellitus	0.000369	0.00223	CcSEcCtD
Isocarboxazid—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000368	0.00222	CcSEcCtD
Isocarboxazid—MAOB—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.000368	0.00607	CbGpPWpGaD
Isocarboxazid—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000364	0.0022	CcSEcCtD
Isocarboxazid—Shock—Metformin—type 2 diabetes mellitus	0.000364	0.00219	CcSEcCtD
Isocarboxazid—Somnolence—Valsartan—type 2 diabetes mellitus	0.000361	0.00217	CcSEcCtD
Isocarboxazid—Syncope—Losartan—type 2 diabetes mellitus	0.000361	0.00217	CcSEcCtD
Isocarboxazid—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00036	0.00217	CcSEcCtD
Isocarboxazid—MAOA—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.000359	0.00592	CbGpPWpGaD
Isocarboxazid—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000357	0.00215	CcSEcCtD
Isocarboxazid—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000356	0.00215	CcSEcCtD
Isocarboxazid—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000356	0.00214	CcSEcCtD
Isocarboxazid—Palpitations—Losartan—type 2 diabetes mellitus	0.000355	0.00214	CcSEcCtD
Isocarboxazid—MAOA—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.000355	0.00585	CbGpPWpGaD
Isocarboxazid—Nausea—Glimepiride—type 2 diabetes mellitus	0.000354	0.00214	CcSEcCtD
Isocarboxazid—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000353	0.00213	CcSEcCtD
Isocarboxazid—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000353	0.00213	CcSEcCtD
Isocarboxazid—Methamphetamine—ADRA2A—type 2 diabetes mellitus	0.000347	0.282	CrCbGaD
Isocarboxazid—Constipation—Valsartan—type 2 diabetes mellitus	0.000347	0.00209	CcSEcCtD
Isocarboxazid—MAOA—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.000346	0.00571	CbGpPWpGaD
Isocarboxazid—Shock—Irbesartan—type 2 diabetes mellitus	0.000343	0.00207	CcSEcCtD
Isocarboxazid—Benzyl alcohol—CYP2E1—type 2 diabetes mellitus	0.000343	0.278	CrCbGaD
Isocarboxazid—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000337	0.00203	CcSEcCtD
Isocarboxazid—Headache—Bromocriptine—type 2 diabetes mellitus	0.000337	0.00203	CcSEcCtD
Isocarboxazid—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000337	0.00203	CcSEcCtD
Isocarboxazid—Dry mouth—Losartan—type 2 diabetes mellitus	0.000335	0.00202	CcSEcCtD
Isocarboxazid—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000332	0.002	CcSEcCtD
Isocarboxazid—MAOA—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.000331	0.00547	CbGpPWpGaD
Isocarboxazid—Somnolence—Metformin—type 2 diabetes mellitus	0.000328	0.00198	CcSEcCtD
Isocarboxazid—Benzyl alcohol—CYP1A2—type 2 diabetes mellitus	0.000326	0.265	CrCbGaD
Isocarboxazid—Tremor—Ramipril—type 2 diabetes mellitus	0.000323	0.00195	CcSEcCtD
Isocarboxazid—Shock—Losartan—type 2 diabetes mellitus	0.000323	0.00195	CcSEcCtD
Isocarboxazid—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00032	0.00193	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000317	0.00191	CcSEcCtD
Isocarboxazid—Agitation—Ramipril—type 2 diabetes mellitus	0.000317	0.00191	CcSEcCtD
Isocarboxazid—Constipation—Metformin—type 2 diabetes mellitus	0.000316	0.00191	CcSEcCtD
Isocarboxazid—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000313	0.00189	CcSEcCtD
Isocarboxazid—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00031	0.00187	CcSEcCtD
Isocarboxazid—Syncope—Ramipril—type 2 diabetes mellitus	0.000309	0.00186	CcSEcCtD
Isocarboxazid—Headache—Glyburide—type 2 diabetes mellitus	0.000308	0.00186	CcSEcCtD
Isocarboxazid—Palpitations—Ramipril—type 2 diabetes mellitus	0.000305	0.00184	CcSEcCtD
Isocarboxazid—MAOB—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000304	0.00501	CbGpPWpGaD
Isocarboxazid—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000303	0.00183	CcSEcCtD
Isocarboxazid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000302	0.00182	CcSEcCtD
Isocarboxazid—MAOB—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.0003	0.00495	CbGpPWpGaD
Isocarboxazid—Constipation—Irbesartan—type 2 diabetes mellitus	0.000298	0.0018	CcSEcCtD
Isocarboxazid—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000295	0.00178	CcSEcCtD
Isocarboxazid—MAOA—Melatonin metabolism and effects—NFKB1—type 2 diabetes mellitus	0.000294	0.00484	CbGpPWpGaD
Isocarboxazid—MAOB—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000293	0.00483	CbGpPWpGaD
Isocarboxazid—Nausea—Glyburide—type 2 diabetes mellitus	0.000292	0.00176	CcSEcCtD
Isocarboxazid—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000292	0.00176	CcSEcCtD
Isocarboxazid—Somnolence—Losartan—type 2 diabetes mellitus	0.000292	0.00176	CcSEcCtD
Isocarboxazid—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000287	0.00173	CcSEcCtD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.000287	0.00473	CbGpPWpGaD
Isocarboxazid—MAOA—Oxidative Stress—NFKB1—type 2 diabetes mellitus	0.000286	0.00471	CbGpPWpGaD
Isocarboxazid—Constipation—Losartan—type 2 diabetes mellitus	0.000281	0.00169	CcSEcCtD
Isocarboxazid—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000278	0.00167	CcSEcCtD
Isocarboxazid—Shock—Ramipril—type 2 diabetes mellitus	0.000277	0.00167	CcSEcCtD
Isocarboxazid—Headache—Gliclazide—type 2 diabetes mellitus	0.000277	0.00167	CcSEcCtD
Isocarboxazid—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000274	0.00165	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000272	0.00164	CcSEcCtD
Isocarboxazid—Dizziness—Valsartan—type 2 diabetes mellitus	0.000268	0.00162	CcSEcCtD
Isocarboxazid—Dizziness—Orlistat—type 2 diabetes mellitus	0.000265	0.0016	CcSEcCtD
Isocarboxazid—Nausea—Gliclazide—type 2 diabetes mellitus	0.000262	0.00158	CcSEcCtD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000258	0.00425	CbGpPWpGaD
Isocarboxazid—Headache—Valsartan—type 2 diabetes mellitus	0.000254	0.00153	CcSEcCtD
Isocarboxazid—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000253	0.00152	CcSEcCtD
Isocarboxazid—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000253	0.00152	CcSEcCtD
Isocarboxazid—MAOA—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000251	0.00414	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000251	0.00414	CbGpPWpGaD
Isocarboxazid—Headache—Orlistat—type 2 diabetes mellitus	0.000251	0.00151	CcSEcCtD
Isocarboxazid—Somnolence—Ramipril—type 2 diabetes mellitus	0.00025	0.00151	CcSEcCtD
Isocarboxazid—Dizziness—Metformin—type 2 diabetes mellitus	0.000244	0.00147	CcSEcCtD
Isocarboxazid—Nausea—Valsartan—type 2 diabetes mellitus	0.000241	0.00145	CcSEcCtD
Isocarboxazid—Constipation—Ramipril—type 2 diabetes mellitus	0.000241	0.00145	CcSEcCtD
Isocarboxazid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000239	0.00144	CcSEcCtD
Isocarboxazid—MAOA—Biological oxidations—MTR—type 2 diabetes mellitus	0.000238	0.00393	CbGpPWpGaD
Isocarboxazid—Nausea—Orlistat—type 2 diabetes mellitus	0.000238	0.00144	CcSEcCtD
Isocarboxazid—Headache—Metformin—type 2 diabetes mellitus	0.000231	0.0014	CcSEcCtD
Isocarboxazid—MAOA—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.000231	0.00381	CbGpPWpGaD
Isocarboxazid—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000231	0.00139	CcSEcCtD
Isocarboxazid—MAOB—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.00023	0.0038	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000225	0.00372	CbGpPWpGaD
Isocarboxazid—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000225	0.00135	CcSEcCtD
Isocarboxazid—MAOA—Neuronal System—GAD2—type 2 diabetes mellitus	0.00022	0.00362	CbGpPWpGaD
Isocarboxazid—Nausea—Metformin—type 2 diabetes mellitus	0.000219	0.00132	CcSEcCtD
Isocarboxazid—Headache—Irbesartan—type 2 diabetes mellitus	0.000218	0.00132	CcSEcCtD
Isocarboxazid—Dizziness—Losartan—type 2 diabetes mellitus	0.000217	0.00131	CcSEcCtD
Isocarboxazid—Benzyl alcohol—CYP3A4—type 2 diabetes mellitus	0.000216	0.175	CrCbGaD
Isocarboxazid—Nausea—Irbesartan—type 2 diabetes mellitus	0.000207	0.00125	CcSEcCtD
Isocarboxazid—Headache—Losartan—type 2 diabetes mellitus	0.000206	0.00124	CcSEcCtD
Isocarboxazid—MAOA—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000199	0.00328	CbGpPWpGaD
Isocarboxazid—Nausea—Losartan—type 2 diabetes mellitus	0.000195	0.00118	CcSEcCtD
Isocarboxazid—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000193	0.00116	CcSEcCtD
Isocarboxazid—MAOA—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000191	0.00314	CbGpPWpGaD
Isocarboxazid—MAOA—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.000188	0.00311	CbGpPWpGaD
Isocarboxazid—Dizziness—Ramipril—type 2 diabetes mellitus	0.000186	0.00112	CcSEcCtD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000185	0.00305	CbGpPWpGaD
Isocarboxazid—MAOA—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000184	0.00303	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.00018	0.00297	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000179	0.00295	CbGpPWpGaD
Isocarboxazid—Headache—Ramipril—type 2 diabetes mellitus	0.000176	0.00106	CcSEcCtD
Isocarboxazid—MAOB—Metabolism—BHMT—type 2 diabetes mellitus	0.000176	0.0029	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000168	0.00278	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000168	0.00278	CbGpPWpGaD
Isocarboxazid—Nausea—Ramipril—type 2 diabetes mellitus	0.000167	0.00101	CcSEcCtD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000166	0.00274	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PTGDS—type 2 diabetes mellitus	0.000153	0.00253	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—AANAT—type 2 diabetes mellitus	0.000153	0.00253	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CDO1—type 2 diabetes mellitus	0.000145	0.0024	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GPD2—type 2 diabetes mellitus	0.000145	0.0024	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000144	0.00238	CbGpPWpGaD
Isocarboxazid—MAOA—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.000144	0.00238	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000141	0.00233	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—AK1—type 2 diabetes mellitus	0.000139	0.00229	CbGpPWpGaD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000138	0.00228	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000132	0.00217	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000128	0.00211	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—MAT1A—type 2 diabetes mellitus	0.000128	0.00211	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ENPP1—type 2 diabetes mellitus	0.000124	0.00204	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—G6PC—type 2 diabetes mellitus	0.000124	0.00204	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000124	0.00204	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—HBA2—type 2 diabetes mellitus	0.000124	0.00204	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ND1—type 2 diabetes mellitus	0.000124	0.00204	CbGpPWpGaD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000123	0.00203	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GCGR—type 2 diabetes mellitus	0.00012	0.00198	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—OXCT1—type 2 diabetes mellitus	0.000113	0.00187	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CYTB—type 2 diabetes mellitus	0.000113	0.00187	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SRD5A1—type 2 diabetes mellitus	0.00011	0.00182	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—BHMT—type 2 diabetes mellitus	0.00011	0.00182	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—GNB3—type 2 diabetes mellitus	0.000106	0.00174	CbGpPWpGaD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000106	0.00174	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—STAR—type 2 diabetes mellitus	0.000105	0.00173	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ACACA—type 2 diabetes mellitus	0.000105	0.00173	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000105	0.00173	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CBS—type 2 diabetes mellitus	0.000101	0.00166	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ABCC8—type 2 diabetes mellitus	0.000101	0.00166	CbGpPWpGaD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	9.93e-05	0.00164	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SLC5A2—type 2 diabetes mellitus	9.7e-05	0.0016	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—COX2—type 2 diabetes mellitus	9.7e-05	0.0016	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—AANAT—type 2 diabetes mellitus	9.63e-05	0.00159	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PTGDS—type 2 diabetes mellitus	9.63e-05	0.00159	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—NCOA6—type 2 diabetes mellitus	9.53e-05	0.00157	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—ADCY5—type 2 diabetes mellitus	9.42e-05	0.00155	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—UCP2—type 2 diabetes mellitus	9.37e-05	0.00155	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—UCP3—type 2 diabetes mellitus	9.37e-05	0.00155	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—HSD11B1—type 2 diabetes mellitus	9.37e-05	0.00155	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CDO1—type 2 diabetes mellitus	9.13e-05	0.00151	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GPD2—type 2 diabetes mellitus	9.13e-05	0.00151	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PCK1—type 2 diabetes mellitus	8.81e-05	0.00145	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—AK1—type 2 diabetes mellitus	8.71e-05	0.00144	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—HK1—type 2 diabetes mellitus	8.25e-05	0.00136	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	8.17e-05	0.00135	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—CALM1—type 2 diabetes mellitus	8.1e-05	0.00134	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—MAT1A—type 2 diabetes mellitus	8.04e-05	0.00133	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SLC5A4—type 2 diabetes mellitus	8.04e-05	0.00133	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—LPA—type 2 diabetes mellitus	7.97e-05	0.00131	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GCKR—type 2 diabetes mellitus	7.97e-05	0.00131	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—HSD3B2—type 2 diabetes mellitus	7.97e-05	0.00131	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—KCNJ11—type 2 diabetes mellitus	7.97e-05	0.00131	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—HBA2—type 2 diabetes mellitus	7.76e-05	0.00128	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ENPP1—type 2 diabetes mellitus	7.76e-05	0.00128	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.76e-05	0.00128	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ND1—type 2 diabetes mellitus	7.76e-05	0.00128	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—G6PC—type 2 diabetes mellitus	7.76e-05	0.00128	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ALDOB—type 2 diabetes mellitus	7.64e-05	0.00126	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	7.64e-05	0.00126	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—PRKCB—type 2 diabetes mellitus	7.61e-05	0.00126	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GCGR—type 2 diabetes mellitus	7.52e-05	0.00124	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GLP1R—type 2 diabetes mellitus	7.1e-05	0.00117	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—OXCT1—type 2 diabetes mellitus	7.1e-05	0.00117	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CYTB—type 2 diabetes mellitus	7.1e-05	0.00117	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	6.93e-05	0.00114	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SRD5A1—type 2 diabetes mellitus	6.92e-05	0.00114	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SLC2A2—type 2 diabetes mellitus	6.63e-05	0.00109	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—STAR—type 2 diabetes mellitus	6.6e-05	0.00109	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—HSD17B3—type 2 diabetes mellitus	6.6e-05	0.00109	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ACACA—type 2 diabetes mellitus	6.6e-05	0.00109	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CPT1A—type 2 diabetes mellitus	6.5e-05	0.00107	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—MTR—type 2 diabetes mellitus	6.5e-05	0.00107	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—NAMPT—type 2 diabetes mellitus	6.37e-05	0.00105	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—LIPC—type 2 diabetes mellitus	6.33e-05	0.00104	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—HBA1—type 2 diabetes mellitus	6.33e-05	0.00104	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GCK—type 2 diabetes mellitus	6.33e-05	0.00104	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CBS—type 2 diabetes mellitus	6.33e-05	0.00104	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ABCC8—type 2 diabetes mellitus	6.33e-05	0.00104	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CYP11A1—type 2 diabetes mellitus	6.29e-05	0.00104	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SLC9A1—type 2 diabetes mellitus	6.18e-05	0.00102	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CETP—type 2 diabetes mellitus	6.11e-05	0.00101	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—COX2—type 2 diabetes mellitus	6.09e-05	0.001	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SLC5A2—type 2 diabetes mellitus	6.09e-05	0.001	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—NCOA6—type 2 diabetes mellitus	5.98e-05	0.000987	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	5.94e-05	0.000981	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—HSD11B1—type 2 diabetes mellitus	5.88e-05	0.00097	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—UCP2—type 2 diabetes mellitus	5.88e-05	0.00097	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—UCP3—type 2 diabetes mellitus	5.88e-05	0.00097	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SREBF1—type 2 diabetes mellitus	5.68e-05	0.000937	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SNAP25—type 2 diabetes mellitus	5.68e-05	0.000937	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PSMD6—type 2 diabetes mellitus	5.68e-05	0.000937	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CTGF—type 2 diabetes mellitus	5.57e-05	0.00092	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PCK1—type 2 diabetes mellitus	5.53e-05	0.000912	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—HMGCR—type 2 diabetes mellitus	5.52e-05	0.000911	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ADRA2A—type 2 diabetes mellitus	5.41e-05	0.000892	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CYP2E1—type 2 diabetes mellitus	5.19e-05	0.000857	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—HK1—type 2 diabetes mellitus	5.18e-05	0.000854	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SLC2A1—type 2 diabetes mellitus	5.14e-05	0.000847	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CYP1A2—type 2 diabetes mellitus	5.14e-05	0.000847	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CYP3A4—type 2 diabetes mellitus	5.01e-05	0.000826	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GCKR—type 2 diabetes mellitus	5e-05	0.000825	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—KCNJ11—type 2 diabetes mellitus	5e-05	0.000825	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—LPA—type 2 diabetes mellitus	5e-05	0.000825	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—HSD3B2—type 2 diabetes mellitus	5e-05	0.000825	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SLC2A4—type 2 diabetes mellitus	4.92e-05	0.000812	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GCG—type 2 diabetes mellitus	4.92e-05	0.000812	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	4.8e-05	0.000791	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ALDOB—type 2 diabetes mellitus	4.79e-05	0.000791	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GLP1R—type 2 diabetes mellitus	4.46e-05	0.000735	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GNB3—type 2 diabetes mellitus	4.24e-05	0.0007	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.24e-05	0.0007	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—HMOX1—type 2 diabetes mellitus	4.22e-05	0.000697	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CAT—type 2 diabetes mellitus	4.17e-05	0.000688	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SLC2A2—type 2 diabetes mellitus	4.16e-05	0.000687	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CPT1A—type 2 diabetes mellitus	4.08e-05	0.000673	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—MTR—type 2 diabetes mellitus	4.08e-05	0.000673	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—APOB—type 2 diabetes mellitus	4.05e-05	0.000668	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—NAMPT—type 2 diabetes mellitus	4e-05	0.00066	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GCK—type 2 diabetes mellitus	3.97e-05	0.000655	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—LIPC—type 2 diabetes mellitus	3.97e-05	0.000655	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—HBA1—type 2 diabetes mellitus	3.97e-05	0.000655	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CYP11A1—type 2 diabetes mellitus	3.95e-05	0.000651	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GSTM1—type 2 diabetes mellitus	3.94e-05	0.000649	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SLC9A1—type 2 diabetes mellitus	3.88e-05	0.00064	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—LPL—type 2 diabetes mellitus	3.86e-05	0.000637	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CETP—type 2 diabetes mellitus	3.83e-05	0.000632	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ADCY5—type 2 diabetes mellitus	3.78e-05	0.000624	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GPX1—type 2 diabetes mellitus	3.77e-05	0.000622	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CD36—type 2 diabetes mellitus	3.67e-05	0.000606	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.62e-05	0.000598	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SNAP25—type 2 diabetes mellitus	3.56e-05	0.000588	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SREBF1—type 2 diabetes mellitus	3.56e-05	0.000588	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PSMD6—type 2 diabetes mellitus	3.56e-05	0.000588	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CTGF—type 2 diabetes mellitus	3.5e-05	0.000577	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—MTHFR—type 2 diabetes mellitus	3.48e-05	0.000574	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—HMGCR—type 2 diabetes mellitus	3.47e-05	0.000572	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PPARA—type 2 diabetes mellitus	3.41e-05	0.000563	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ADRA2A—type 2 diabetes mellitus	3.39e-05	0.00056	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—AGT—type 2 diabetes mellitus	3.31e-05	0.000545	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CYP2E1—type 2 diabetes mellitus	3.26e-05	0.000538	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CALM1—type 2 diabetes mellitus	3.25e-05	0.000536	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—APOE—type 2 diabetes mellitus	3.24e-05	0.000534	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CYP1A2—type 2 diabetes mellitus	3.22e-05	0.000532	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SLC2A1—type 2 diabetes mellitus	3.22e-05	0.000532	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—APOA1—type 2 diabetes mellitus	3.2e-05	0.000528	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CYP3A4—type 2 diabetes mellitus	3.14e-05	0.000518	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GCG—type 2 diabetes mellitus	3.09e-05	0.00051	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SLC2A4—type 2 diabetes mellitus	3.09e-05	0.00051	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PPARG—type 2 diabetes mellitus	2.82e-05	0.000465	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—INS—type 2 diabetes mellitus	2.77e-05	0.000456	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GNB3—type 2 diabetes mellitus	2.66e-05	0.000439	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.66e-05	0.000439	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—HMOX1—type 2 diabetes mellitus	2.65e-05	0.000437	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CAT—type 2 diabetes mellitus	2.62e-05	0.000431	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—APOB—type 2 diabetes mellitus	2.54e-05	0.000419	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ALB—type 2 diabetes mellitus	2.54e-05	0.000418	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GSTM1—type 2 diabetes mellitus	2.47e-05	0.000407	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.43e-05	0.0004	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—NOS3—type 2 diabetes mellitus	2.43e-05	0.0004	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—LPL—type 2 diabetes mellitus	2.42e-05	0.0004	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ADCY5—type 2 diabetes mellitus	2.37e-05	0.000392	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GPX1—type 2 diabetes mellitus	2.37e-05	0.00039	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CD36—type 2 diabetes mellitus	2.3e-05	0.00038	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PPP2CA—type 2 diabetes mellitus	2.27e-05	0.000375	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PTGS2—type 2 diabetes mellitus	2.22e-05	0.000366	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—MTHFR—type 2 diabetes mellitus	2.18e-05	0.00036	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PPARA—type 2 diabetes mellitus	2.14e-05	0.000353	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—AGT—type 2 diabetes mellitus	2.07e-05	0.000342	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CALM1—type 2 diabetes mellitus	2.04e-05	0.000336	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—APOE—type 2 diabetes mellitus	2.03e-05	0.000335	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—APOA1—type 2 diabetes mellitus	2.01e-05	0.000331	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PPARG—type 2 diabetes mellitus	1.77e-05	0.000292	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—INS—type 2 diabetes mellitus	1.74e-05	0.000286	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ALB—type 2 diabetes mellitus	1.59e-05	0.000263	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—NOS3—type 2 diabetes mellitus	1.52e-05	0.000251	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PIK3R1—type 2 diabetes mellitus	1.52e-05	0.000251	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PTGS2—type 2 diabetes mellitus	1.39e-05	0.00023	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—AKT1—type 2 diabetes mellitus	1.12e-05	0.000184	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	7e-06	0.000115	CbGpPWpGaD
